Ultrasound-Enhancing Agent Safety: Understanding the New Food and Drug Administration Warning on Polyethylene Glycol

IN APRIL 2021, the Food and Drug Administration (FDA) issued an alert stating ultrasound-enhancing agents (UEA) should not be administered to patients with known hypersensitivity reactions to polyethylene glycol (PEG). In response, several societies, including the International Contrast Ultrasound Society and the American Society of Echocardiography, have issued and published statements providing education and guidance on this topic.1

Source: Journal of Cardiothoracic and Vascular Anesthesia - July 13, 2021 Category: Anesthesiology Authors: Tiffany M. Williams, Reed Harvey, Wolf B. Kratzert, Matthew A. Fischer, Jacques Neelankavil Tags: Editorial Source Type: research